Sinobay

About:

Sinobay develops biotechnology for tumor treatment and the proliferation of CD8+T & CAR-T cells in vitro.

Website: http://www.sinobay.sh.cn

Top Investors: Lead Capital

Description:

Total Funding Amount:

10M CNY

Headquarters Location:

Jinshan, Shanghai, China

Founded Date:

2017-12-29

Founders:

Number of Employees:

51-100

Last Funding Date:

2018-02-01

IPO Status:

Private

Industries: